PGXL Technologies announced it has received a contract to help the According to a release, the
"There was no other applicant who could isolate and manipulate individual cells the way we can," says Dr.
PGXL noted it uses DEPArray Technology to work with individual cells. Developed by Silicon Biosystems, DEPArray is the most advanced single-cell-isolation technology in the world. PGXL and Silicon Biosystems will collaborate to develop a way to identify and isolate CTCs that are invisible to conventional technology. The DEPArray enables clinical researchers and pharma sponsors to obtain the level of data fidelity and resolution needed in cancer biomarker discovery and translational research.
PGXL Technologies is a company focused on clinical application of pharmacogenetic and molecular diagnostic testing for personalized medicine.
Silicon Biosystems is a medical device manufacturer.
((Comments on this story may be sent to email@example.com))
PGXL Technologies announced it has received a contract to help the
According to a release, the